We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Whole Genome Sequencing Detects Infection Transmission in NICU

By LabMedica International staff writers
Posted on 23 May 2024
Print article
Image: NGD’s automated bioinformatic systems facilitate use of WGS to detect transmission in NICUs (Photo courtesy of NGD)
Image: NGD’s automated bioinformatic systems facilitate use of WGS to detect transmission in NICUs (Photo courtesy of NGD)

A new study has shown that whole genome sequencing (WGS) of bacterial pathogens acquired from surveillance in a neonatal intensive care unit (NICU) can reveal significant infection transmission that goes undetected by standard infection control measures. The research highlights that even in well-equipped medical facilities and in areas like the NICU where vigilant monitoring is routine, WGS provides a level of detection of transmission events that current methods cannot achieve.

Conducted by Next Gen Diagnostics (NGD, West Palm Beach, FL, USA) and researchers from Vanderbilt University Medical Center (VUMC, Nashville, TN, USA), the study analyzed 171 S. aureus samples from 132 individual patients. These samples were collected during routine surveillance in April, June, and July, and were supplemented with clinical samples. The samples were sequenced using short-read sequencing techniques and analyzed by NGD’s automated system to determine the relatedness of core genomes at the SNP level.

A stringent cutoff of 6 SNPs was used to identify potential transmission, which was then further assessed by the VUMC infection prevention team. The analysis found that 42 out of 132 patients (31.8%) with S. aureus infections were linked by transmission chains. Notably, the incidence of patients with MRSA infections connected by transmission was 46.8%, more than double the rate found in patients with MSSA infections, which stood at 21.2%. The study identified 13 distinct strains involved in these transmissions, indicating localized, undetected sources of spread rather than a ward-wide outbreak.

“We found that WGS of S. aureus isolates obtained from surveillance swabs and clinical samples revealed a significant amount of likely transmission, which provided guidance enabling our infection control team to take a series of actions with beneficial effect,” said Dr. Romney Humphries, Professor of Pathology, Microbiology and Immunology and Director of Laboratory Medicine at VUMC and senior author on the study.

“This result, along with those emerging from other medical centers, of the use of WGS to detect rather than simply verify transmission may signal a sea-change in best practice,” added Tom Talbot, Professor of Medicine and Medical Director of Infection Prevention at VUMC. “With a sufficiently low cost for sequencing and bioinformatic analysis, use of WGS to detect transmission, at least in those wards where patients are at the greatest risk, may become a more routine infection prevention practice.”

Related Links:
NGD
VUMC

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.